MENOPUR® Versus FOLLISTIM®

• Status: Completed
• Trial end date: 2010-01-01

Summary

To compare the efficacy and safety of highly purified menotropin (Menopur®) with that of follitropin beta (FOLLISTIM®) in patients who are undergoing gonadotropin-releasing hormone (GnRH) antagonist in vitro fertilization (IVF) cycles

• Phase: Phase 4

Details

• Lead Sponsor: Ferring Pharmaceuticals
• Treatments: Chorionic Gonadotropin; Follicle Stimulating Hormone; Ganirelix; Menotropins; Progesterone